Local Anesthetic Metabolism Upd

To understand metabolism, we must first understand the agent. Most local anesthetics—like Lidocaine or Bupivacaine—are weak bases. But to reach their target (the inside of the nerve fiber), they must cross a fatty membrane. To do this, they are designed to be "lipophilic" (fat-loving).

Amide LAs undergo complex biotransformation almost exclusively in the . They are not hydrolyzed in plasma. The process involves:

Local anesthetics are widely used in various medical and dental procedures to provide pain relief. While their mechanism of action and effects on the nervous system are well understood, the metabolism of local anesthetics is a critical aspect that impacts their safety and efficacy. This review aims to summarize the current knowledge on local anesthetic metabolism, highlighting the key enzymes, pathways, and factors that influence their breakdown. local anesthetic metabolism

There is a profound tension in this process. The drug works because it stays in the nerve. But if it stays too long, it becomes toxic.

The Phase I metabolites (often still active, but less potent and more toxic in some cases) undergo glucuronidation or further conjugation for renal excretion. To understand metabolism, we must first understand the agent

Several factors can influence local anesthetic metabolism, including:

The dichotomy between (plasma pseudocholinesterase) and amide (hepatic CYP450) metabolism dictates the clinical safety profile, duration, and patient selection for local anesthetics. While esters offer safety in liver disease, their allergy potential and short duration limit use. Amides provide longer action but require intact hepatic function and awareness of drug interactions. A deep understanding of these pathways allows the clinician to prevent systemic toxicity, recognize genetic variants, and tailor anesthetic choice to individual patient physiology. To do this, they are designed to be